Global Endocannabinoid System Targeted Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview
Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
This report provides a deep insight into the global Endocannabinoid System Targeted Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Endocannabinoid System Targeted Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Endocannabinoid System Targeted Therapeutics market in any manner.
Global Endocannabinoid System Targeted Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
Market Segmentation (by Type)
Oral
Inhalation
Others
Market Segmentation (by Application)
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Endocannabinoid System Targeted Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
This report provides a deep insight into the global Endocannabinoid System Targeted Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Endocannabinoid System Targeted Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Endocannabinoid System Targeted Therapeutics market in any manner.
Global Endocannabinoid System Targeted Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
Market Segmentation (by Type)
Oral
Inhalation
Others
Market Segmentation (by Application)
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Endocannabinoid System Targeted Therapeutics Market
- Overview of the regional outlook of the Endocannabinoid System Targeted Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Endocannabinoid System Targeted Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Endocannabinoid System Targeted Therapeutics
1.2 Key Market Segments
1.2.1 Endocannabinoid System Targeted Therapeutics Segment by Type
1.2.2 Endocannabinoid System Targeted Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Endocannabinoid System Targeted Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Endocannabinoid System Targeted Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Endocannabinoid System Targeted Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Endocannabinoid System Targeted Therapeutics Sales Sites, Area Served, Product Type
3.6 Endocannabinoid System Targeted Therapeutics Market Competitive Situation and Trends
3.6.1 Endocannabinoid System Targeted Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Endocannabinoid System Targeted Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Endocannabinoid System Targeted Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Endocannabinoid System Targeted Therapeutics Price by Type (2019-2024)
7 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Endocannabinoid System Targeted Therapeutics Market Sales by Application (2019-2024)
7.3 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2019-2024)
8 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Endocannabinoid System Targeted Therapeutics Sales by Region
8.1.1 Global Endocannabinoid System Targeted Therapeutics Sales by Region
8.1.2 Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Endocannabinoid System Targeted Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Endocannabinoid System Targeted Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Endocannabinoid System Targeted Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Endocannabinoid System Targeted Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GW Pharmaceuticals
9.1.1 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
9.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
9.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
9.1.4 GW Pharmaceuticals Business Overview
9.1.5 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics SWOT Analysis
9.1.6 GW Pharmaceuticals Recent Developments
9.2 MAKScientific
9.2.1 MAKScientific Endocannabinoid System Targeted Therapeutics Basic Information
9.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Product Overview
9.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Product Market Performance
9.2.4 MAKScientific Business Overview
9.2.5 MAKScientific Endocannabinoid System Targeted Therapeutics SWOT Analysis
9.2.6 MAKScientific Recent Developments
9.3 Corbus Pharmaceuticals
9.3.1 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
9.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
9.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
9.3.4 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics SWOT Analysis
9.3.5 Corbus Pharmaceuticals Business Overview
9.3.6 Corbus Pharmaceuticals Recent Developments
9.4 Tilray
9.4.1 Tilray Endocannabinoid System Targeted Therapeutics Basic Information
9.4.2 Tilray Endocannabinoid System Targeted Therapeutics Product Overview
9.4.3 Tilray Endocannabinoid System Targeted Therapeutics Product Market Performance
9.4.4 Tilray Business Overview
9.4.5 Tilray Recent Developments
9.5 Pure Green
9.5.1 Pure Green Endocannabinoid System Targeted Therapeutics Basic Information
9.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Product Overview
9.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Product Market Performance
9.5.4 Pure Green Business Overview
9.5.5 Pure Green Recent Developments
9.6 Avicanna
9.6.1 Avicanna Endocannabinoid System Targeted Therapeutics Basic Information
9.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Product Overview
9.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Product Market Performance
9.6.4 Avicanna Business Overview
9.6.5 Avicanna Recent Developments
9.7 GB Sciences
9.7.1 GB Sciences Endocannabinoid System Targeted Therapeutics Basic Information
9.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Product Overview
9.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Product Market Performance
9.7.4 GB Sciences Business Overview
9.7.5 GB Sciences Recent Developments
9.8 Botanix Pharmaceuticals
9.8.1 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
9.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
9.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
9.8.4 Botanix Pharmaceuticals Business Overview
9.8.5 Botanix Pharmaceuticals Recent Developments
9.9 Therapix Biosciences
9.9.1 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Basic Information
9.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Overview
9.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Market Performance
9.9.4 Therapix Biosciences Business Overview
9.9.5 Therapix Biosciences Recent Developments
9.10 Zelira Therapeutics
9.10.1 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Basic Information
9.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Overview
9.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Market Performance
9.10.4 Zelira Therapeutics Business Overview
9.10.5 Zelira Therapeutics Recent Developments
10 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Endocannabinoid System Targeted Therapeutics Market Size Forecast
10.2 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region
10.2.4 South America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Endocannabinoid System Targeted Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Endocannabinoid System Targeted Therapeutics by Type (2025-2030)
11.1.2 Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Endocannabinoid System Targeted Therapeutics by Type (2025-2030)
11.2 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Endocannabinoid System Targeted Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Endocannabinoid System Targeted Therapeutics
1.2 Key Market Segments
1.2.1 Endocannabinoid System Targeted Therapeutics Segment by Type
1.2.2 Endocannabinoid System Targeted Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Endocannabinoid System Targeted Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Endocannabinoid System Targeted Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Endocannabinoid System Targeted Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Endocannabinoid System Targeted Therapeutics Sales Sites, Area Served, Product Type
3.6 Endocannabinoid System Targeted Therapeutics Market Competitive Situation and Trends
3.6.1 Endocannabinoid System Targeted Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Endocannabinoid System Targeted Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Endocannabinoid System Targeted Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Endocannabinoid System Targeted Therapeutics Price by Type (2019-2024)
7 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Endocannabinoid System Targeted Therapeutics Market Sales by Application (2019-2024)
7.3 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2019-2024)
8 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Endocannabinoid System Targeted Therapeutics Sales by Region
8.1.1 Global Endocannabinoid System Targeted Therapeutics Sales by Region
8.1.2 Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Endocannabinoid System Targeted Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Endocannabinoid System Targeted Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Endocannabinoid System Targeted Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Endocannabinoid System Targeted Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GW Pharmaceuticals
9.1.1 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
9.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
9.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
9.1.4 GW Pharmaceuticals Business Overview
9.1.5 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics SWOT Analysis
9.1.6 GW Pharmaceuticals Recent Developments
9.2 MAKScientific
9.2.1 MAKScientific Endocannabinoid System Targeted Therapeutics Basic Information
9.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Product Overview
9.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Product Market Performance
9.2.4 MAKScientific Business Overview
9.2.5 MAKScientific Endocannabinoid System Targeted Therapeutics SWOT Analysis
9.2.6 MAKScientific Recent Developments
9.3 Corbus Pharmaceuticals
9.3.1 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
9.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
9.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
9.3.4 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics SWOT Analysis
9.3.5 Corbus Pharmaceuticals Business Overview
9.3.6 Corbus Pharmaceuticals Recent Developments
9.4 Tilray
9.4.1 Tilray Endocannabinoid System Targeted Therapeutics Basic Information
9.4.2 Tilray Endocannabinoid System Targeted Therapeutics Product Overview
9.4.3 Tilray Endocannabinoid System Targeted Therapeutics Product Market Performance
9.4.4 Tilray Business Overview
9.4.5 Tilray Recent Developments
9.5 Pure Green
9.5.1 Pure Green Endocannabinoid System Targeted Therapeutics Basic Information
9.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Product Overview
9.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Product Market Performance
9.5.4 Pure Green Business Overview
9.5.5 Pure Green Recent Developments
9.6 Avicanna
9.6.1 Avicanna Endocannabinoid System Targeted Therapeutics Basic Information
9.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Product Overview
9.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Product Market Performance
9.6.4 Avicanna Business Overview
9.6.5 Avicanna Recent Developments
9.7 GB Sciences
9.7.1 GB Sciences Endocannabinoid System Targeted Therapeutics Basic Information
9.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Product Overview
9.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Product Market Performance
9.7.4 GB Sciences Business Overview
9.7.5 GB Sciences Recent Developments
9.8 Botanix Pharmaceuticals
9.8.1 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
9.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
9.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
9.8.4 Botanix Pharmaceuticals Business Overview
9.8.5 Botanix Pharmaceuticals Recent Developments
9.9 Therapix Biosciences
9.9.1 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Basic Information
9.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Overview
9.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Market Performance
9.9.4 Therapix Biosciences Business Overview
9.9.5 Therapix Biosciences Recent Developments
9.10 Zelira Therapeutics
9.10.1 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Basic Information
9.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Overview
9.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Market Performance
9.10.4 Zelira Therapeutics Business Overview
9.10.5 Zelira Therapeutics Recent Developments
10 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Endocannabinoid System Targeted Therapeutics Market Size Forecast
10.2 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region
10.2.4 South America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Endocannabinoid System Targeted Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Endocannabinoid System Targeted Therapeutics by Type (2025-2030)
11.1.2 Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Endocannabinoid System Targeted Therapeutics by Type (2025-2030)
11.2 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Endocannabinoid System Targeted Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Endocannabinoid System Targeted Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Endocannabinoid System Targeted Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2022)
Table 10. Global Market Endocannabinoid System Targeted Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Endocannabinoid System Targeted Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Endocannabinoid System Targeted Therapeutics Product Type
Table 13. Global Endocannabinoid System Targeted Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Endocannabinoid System Targeted Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Endocannabinoid System Targeted Therapeutics Market Challenges
Table 22. Global Endocannabinoid System Targeted Therapeutics Sales by Type (K Units)
Table 23. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (M USD)
Table 24. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Endocannabinoid System Targeted Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Endocannabinoid System Targeted Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Application
Table 30. Global Endocannabinoid System Targeted Therapeutics Market Size by Application
Table 31. Global Endocannabinoid System Targeted Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Endocannabinoid System Targeted Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Endocannabinoid System Targeted Therapeutics Market Share by Application (2019-2024)
Table 35. Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Endocannabinoid System Targeted Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Endocannabinoid System Targeted Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Endocannabinoid System Targeted Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Endocannabinoid System Targeted Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
Table 44. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 45. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GW Pharmaceuticals Business Overview
Table 47. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics SWOT Analysis
Table 48. GW Pharmaceuticals Recent Developments
Table 49. MAKScientific Endocannabinoid System Targeted Therapeutics Basic Information
Table 50. MAKScientific Endocannabinoid System Targeted Therapeutics Product Overview
Table 51. MAKScientific Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. MAKScientific Business Overview
Table 53. MAKScientific Endocannabinoid System Targeted Therapeutics SWOT Analysis
Table 54. MAKScientific Recent Developments
Table 55. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
Table 56. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 57. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics SWOT Analysis
Table 59. Corbus Pharmaceuticals Business Overview
Table 60. Corbus Pharmaceuticals Recent Developments
Table 61. Tilray Endocannabinoid System Targeted Therapeutics Basic Information
Table 62. Tilray Endocannabinoid System Targeted Therapeutics Product Overview
Table 63. Tilray Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Tilray Business Overview
Table 65. Tilray Recent Developments
Table 66. Pure Green Endocannabinoid System Targeted Therapeutics Basic Information
Table 67. Pure Green Endocannabinoid System Targeted Therapeutics Product Overview
Table 68. Pure Green Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pure Green Business Overview
Table 70. Pure Green Recent Developments
Table 71. Avicanna Endocannabinoid System Targeted Therapeutics Basic Information
Table 72. Avicanna Endocannabinoid System Targeted Therapeutics Product Overview
Table 73. Avicanna Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Avicanna Business Overview
Table 75. Avicanna Recent Developments
Table 76. GB Sciences Endocannabinoid System Targeted Therapeutics Basic Information
Table 77. GB Sciences Endocannabinoid System Targeted Therapeutics Product Overview
Table 78. GB Sciences Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. GB Sciences Business Overview
Table 80. GB Sciences Recent Developments
Table 81. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
Table 82. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 83. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Botanix Pharmaceuticals Business Overview
Table 85. Botanix Pharmaceuticals Recent Developments
Table 86. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Basic Information
Table 87. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Overview
Table 88. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Therapix Biosciences Business Overview
Table 90. Therapix Biosciences Recent Developments
Table 91. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Basic Information
Table 92. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Overview
Table 93. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Zelira Therapeutics Business Overview
Table 95. Zelira Therapeutics Recent Developments
Table 96. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Endocannabinoid System Targeted Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Endocannabinoid System Targeted Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Endocannabinoid System Targeted Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2022)
Table 10. Global Market Endocannabinoid System Targeted Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Endocannabinoid System Targeted Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Endocannabinoid System Targeted Therapeutics Product Type
Table 13. Global Endocannabinoid System Targeted Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Endocannabinoid System Targeted Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Endocannabinoid System Targeted Therapeutics Market Challenges
Table 22. Global Endocannabinoid System Targeted Therapeutics Sales by Type (K Units)
Table 23. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (M USD)
Table 24. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Endocannabinoid System Targeted Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Endocannabinoid System Targeted Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Application
Table 30. Global Endocannabinoid System Targeted Therapeutics Market Size by Application
Table 31. Global Endocannabinoid System Targeted Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Endocannabinoid System Targeted Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Endocannabinoid System Targeted Therapeutics Market Share by Application (2019-2024)
Table 35. Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Endocannabinoid System Targeted Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Endocannabinoid System Targeted Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Endocannabinoid System Targeted Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Endocannabinoid System Targeted Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
Table 44. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 45. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GW Pharmaceuticals Business Overview
Table 47. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics SWOT Analysis
Table 48. GW Pharmaceuticals Recent Developments
Table 49. MAKScientific Endocannabinoid System Targeted Therapeutics Basic Information
Table 50. MAKScientific Endocannabinoid System Targeted Therapeutics Product Overview
Table 51. MAKScientific Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. MAKScientific Business Overview
Table 53. MAKScientific Endocannabinoid System Targeted Therapeutics SWOT Analysis
Table 54. MAKScientific Recent Developments
Table 55. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
Table 56. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 57. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics SWOT Analysis
Table 59. Corbus Pharmaceuticals Business Overview
Table 60. Corbus Pharmaceuticals Recent Developments
Table 61. Tilray Endocannabinoid System Targeted Therapeutics Basic Information
Table 62. Tilray Endocannabinoid System Targeted Therapeutics Product Overview
Table 63. Tilray Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Tilray Business Overview
Table 65. Tilray Recent Developments
Table 66. Pure Green Endocannabinoid System Targeted Therapeutics Basic Information
Table 67. Pure Green Endocannabinoid System Targeted Therapeutics Product Overview
Table 68. Pure Green Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Pure Green Business Overview
Table 70. Pure Green Recent Developments
Table 71. Avicanna Endocannabinoid System Targeted Therapeutics Basic Information
Table 72. Avicanna Endocannabinoid System Targeted Therapeutics Product Overview
Table 73. Avicanna Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Avicanna Business Overview
Table 75. Avicanna Recent Developments
Table 76. GB Sciences Endocannabinoid System Targeted Therapeutics Basic Information
Table 77. GB Sciences Endocannabinoid System Targeted Therapeutics Product Overview
Table 78. GB Sciences Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. GB Sciences Business Overview
Table 80. GB Sciences Recent Developments
Table 81. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Basic Information
Table 82. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 83. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Botanix Pharmaceuticals Business Overview
Table 85. Botanix Pharmaceuticals Recent Developments
Table 86. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Basic Information
Table 87. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Overview
Table 88. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Therapix Biosciences Business Overview
Table 90. Therapix Biosciences Recent Developments
Table 91. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Basic Information
Table 92. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Overview
Table 93. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Zelira Therapeutics Business Overview
Table 95. Zelira Therapeutics Recent Developments
Table 96. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Endocannabinoid System Targeted Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Endocannabinoid System Targeted Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Endocannabinoid System Targeted Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Endocannabinoid System Targeted Therapeutics Market Size by Country (M USD)
Figure 11. Endocannabinoid System Targeted Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Endocannabinoid System Targeted Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Endocannabinoid System Targeted Therapeutics Market Share by Type
Figure 18. Sales Market Share of Endocannabinoid System Targeted Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Endocannabinoid System Targeted Therapeutics by Type in 2023
Figure 20. Market Size Share of Endocannabinoid System Targeted Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Endocannabinoid System Targeted Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Endocannabinoid System Targeted Therapeutics Market Share by Application
Figure 24. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Endocannabinoid System Targeted Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Endocannabinoid System Targeted Therapeutics Market Share by Application in 2023
Figure 28. Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Endocannabinoid System Targeted Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Endocannabinoid System Targeted Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Market Share by Region in 2023
Figure 44. China Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Endocannabinoid System Targeted Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Endocannabinoid System Targeted Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Endocannabinoid System Targeted Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Endocannabinoid System Targeted Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Endocannabinoid System Targeted Therapeutics Market Size by Country (M USD)
Figure 11. Endocannabinoid System Targeted Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Endocannabinoid System Targeted Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Endocannabinoid System Targeted Therapeutics Market Share by Type
Figure 18. Sales Market Share of Endocannabinoid System Targeted Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Endocannabinoid System Targeted Therapeutics by Type in 2023
Figure 20. Market Size Share of Endocannabinoid System Targeted Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Endocannabinoid System Targeted Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Endocannabinoid System Targeted Therapeutics Market Share by Application
Figure 24. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Endocannabinoid System Targeted Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Endocannabinoid System Targeted Therapeutics Market Share by Application in 2023
Figure 28. Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Endocannabinoid System Targeted Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Endocannabinoid System Targeted Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Market Share by Region in 2023
Figure 44. China Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Endocannabinoid System Targeted Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Endocannabinoid System Targeted Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Endocannabinoid System Targeted Therapeutics Market Share Forecast by Application (2025-2030)
